ALNY

Alnylam Pharmaceuticals (ALNY)

About Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Details

Daily high

$298.23

Daily low

$288.74

Price at open

52 Week High

$304.39

52 Week Low

$146.79

Market cap

38.1B

Dividend yield

0.00%

Volume

930,234

Avg. volume

985,453

P/E ratio

-139.80

Alnylam Pharmaceuticals News